BMRN

$56.121.77%-1.01

After Hours: 56.120.00 0.00%

Biomarin Pharmaceutical Inc (BMRN)

Biomarin Pharmaceutical Inc Stock (BMRN) Forecast

The Biomarin Pharmaceutical Inc (BMRN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $61.00, representing a +8.70% increase from the current price of $56.12. The highest analyst price target is $66.32, and the lowest is $55.68.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month BMRN Price Target

Average 59.74 (+6.44% Upside)

Is Biomarin Pharmaceutical Inc (BMRN) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	45.56	Neutral
STOCH(9,6)	67.99	Neutral
STOCHRSI(14)	61.31	Neutral
MACD(12,26)	-0.66	Buy
ADX(14)	24.30	Neutral
William %R	-45.15	Neutral
CCI(14)	34.91	Neutral

Buy: 1 · Sell: 0 · Neutral: 6Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	56.54 Sell	56.54 Sell
MA20	55.94 Buy	56.79 Sell
MA50	59.87 Sell	58.56 Sell
MA100	60.54 Sell	59.19 Sell
MA200	58.45 Sell	58.58 Sell

Buy: 1 · Sell: 9 · Neutral: 0Summary: Sell

According to our latest analysis, BMRN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 9 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on BMRN, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 45.56 indicates that BMRN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 67.99 indicates that BMRN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 61.31 indicates that BMRN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 24.30 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
CCI (Commodity Channel Index): A CCI(14) value of 34.91 indicates that BMRN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term BMRN price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Biomarin Pharmaceutical Inc financial reports and earnings history, Biomarin Pharmaceutical Inc (BMRN) stock could reach $73.73 by 2030, $32.95 by 2040 and $45.22 by 2050. See the projected annual prices until 2050 of the Biomarin Pharmaceutical Inc stock below:

Biomarin Pharmaceutical Inc (BMRN) is expected to reach an average price of $25.42 in 2035, with a high prediction of $52.61 and a low estimate of $19.72. This indicates an -54.70% change from the last recorded price of $56.12.
Biomarin Pharmaceutical Inc (BMRN) stock is projected to chart a bullish course in 2040, with an average price target of $17.69, representing an -68.48% change from its current level. The forecast ranges from a conservative $8.82 to a sky-high $32.95.
Our analysts predict Biomarin Pharmaceutical Inc (BMRN) to change -96.38% by 2045, soaring from $0.3529 to an average price of $2.03, potentially reaching $23.16. While $0.3529 is the low estimate, the potential upside is significant.
Biomarin Pharmaceutical Inc (BMRN) stock is expected to climb by 2050, reaching an average of $16.10, a -71.30% change from its current level. However, a wide range of estimates exists, with high and low targets of $45.22 and $3.57, respectively, highlighting the market's uncertainty.

Biomarin Pharmaceutical Inc Stock (BMRN) Year by Year Forecast

Biomarin Pharmaceutical Inc Stock (BMRN) Price Forecast for 2026

The predicted value for Biomarin Pharmaceutical Inc (BMRN) in 2026 is set at an average of $59.45. Estimates vary from a peak of $70.98 to a trough of $49.26, indicating an +5.94% surge from the present price of $56.12.

Month	Average	Low	High	Change from today's price
December, 2026	$65.74	$55.68	$66.32	+17.14%

Biomarin Pharmaceutical Inc Stock (BMRN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Biomarin Pharmaceutical Inc (BMRN) is $59.74, with a high forecast of $73.37 and a low forecast of $46.10. This indicates an +6.46% increase from the last price of $56.12.

Month	Average	Low	High	Change from today's price
January, 2027	$59.34	$56.66	$65.79	+5.74%
February, 2027	$65.71	$55.83	$69.00	+17.08%
March, 2027	$50.91	$46.85	$68.06	-9.28%
April, 2027	$54.31	$49.96	$57.56	-3.22%
May, 2027	$54.44	$53.53	$61.66	-3.00%
June, 2027	$50.42	$49.14	$56.46	-10.16%
July, 2027	$62.25	$46.10	$62.38	+10.92%
August, 2027	$60.76	$57.25	$65.95	+8.27%
September, 2027	$68.48	$60.24	$73.37	+22.03%
October, 2027	$68.68	$64.04	$70.00	+22.38%
November, 2027	$63.14	$57.49	$67.92	+12.50%
December, 2027	$58.48	$57.53	$68.70	+4.21%

Biomarin Pharmaceutical Inc Stock (BMRN) Price Forecast for 2028

In 2028, Biomarin Pharmaceutical Inc (BMRN) is projected to reach an average price of $73.44, with a high projection of $94.12 and a low estimate of $56.55. This indicates an +30.86% rise from the last price of $56.12.

Month	Average	Low	High	Change from today's price
January, 2028	$81.69	$56.55	$82.85	+45.56%
February, 2028	$79.73	$77.19	$85.75	+42.07%
March, 2028	$93.62	$76.79	$94.12	+66.82%
April, 2028	$84.77	$82.39	$93.87	+51.05%
May, 2028	$68.26	$63.93	$84.92	+21.64%
June, 2028	$75.71	$65.96	$76.48	+34.91%
July, 2028	$68.74	$66.01	$77.11	+22.48%
August, 2028	$68.31	$62.58	$70.44	+21.72%
September, 2028	$62.13	$60.91	$73.65	+10.70%
October, 2028	$65.73	$61.38	$66.81	+17.13%
November, 2028	$68.68	$64.47	$72.43	+22.38%
December, 2028	$63.92	$63.17	$71.06	+13.90%

Biomarin Pharmaceutical Inc Stock (BMRN) Price Forecast for 2029

The 2029 price forecast for Biomarin Pharmaceutical Inc Stock (BMRN) is $64.19 on average, with a high prediction of $77.35 and a low estimate of $52.20. This represents an +14.38% increase from the previous price of $56.12.

Month	Average	Low	High	Change from today's price
January, 2029	$58.22	$57.79	$68.21	+3.73%
February, 2029	$65.17	$53.62	$65.85	+16.13%
March, 2029	$70.70	$64.55	$73.18	+25.99%
April, 2029	$71.23	$70.23	$77.35	+26.92%
May, 2029	$66.12	$65.27	$72.46	+17.82%
June, 2029	$64.40	$63.66	$72.24	+14.75%
July, 2029	$65.59	$61.64	$66.99	+16.88%
August, 2029	$59.27	$59.26	$71.69	+5.62%
September, 2029	$56.03	$54.61	$63.45	-0.16%
October, 2029	$62.39	$52.20	$64.73	+11.17%
November, 2029	$62.81	$59.19	$64.96	+11.91%
December, 2029	$68.38	$58.88	$69.87	+21.85%

Biomarin Pharmaceutical Inc Stock (BMRN) Price Forecast for 2030

Biomarin Pharmaceutical Inc Stock (BMRN) is expected to reach an average price of $45.14 in 2030, with a high forecast of $73.73 and a low forecast of $32.81. This signifies an -19.57% decrease from the last price of $56.12.

Month	Average	Low	High	Change from today's price
January, 2030	$63.86	$62.39	$73.73	+13.79%
February, 2030	$48.58	$46.76	$56.99	-13.44%
March, 2030	$45.07	$44.53	$50.13	-19.69%
April, 2030	$45.34	$40.44	$47.21	-19.20%
May, 2030	$46.31	$42.18	$47.25	-17.48%
June, 2030	$41.06	$40.16	$49.20	-26.83%
July, 2030	$47.92	$40.73	$50.17	-14.62%
August, 2030	$51.02	$47.38	$53.23	-9.09%
September, 2030	$39.08	$32.81	$52.98	-30.36%
October, 2030	$38.88	$38.23	$45.39	-30.72%
November, 2030	$36.78	$35.28	$42.35	-34.46%
December, 2030	$37.77	$33.93	$38.34	-32.71%

Similar to BMRN